We used CyTOF to assess tumor-resident T cells in tumors ± GCSF secretion and found that virtually all signaling was reduced in the absence of tumor GCSF, with a significant decrease in pSTAT5 in both CD4+ and CD8+ T cells, and pSTAT3 in CD4+ T cells. This evidence concerns the gene CD4 and neoplasm.